Analysts have been eager to weigh in on the Healthcare sector with new ratings on Alkermes (ALKS) and Roche Holding AG (RHHVF).
Alkermes (ALKS)
Mizuho Securities analyst Vamil Divan maintained a Hold rating on Alkermes today and set a price target of $16.00. The company’s shares closed last Tuesday at $20.18.
According to TipRanks.com, Divan is a 1-star analyst with an average return of -1.4% and a 45.7% success rate. Divan covers the Healthcare sector, focusing on stocks such as Biohaven Pharmaceutical Holding Co, Satsuma Pharmaceuticals, and Karuna Therapeutics.
The word on The Street in general, suggests a Hold analyst consensus rating for Alkermes with a $19.67 average price target.
See today’s analyst top recommended stocks >>
Roche Holding AG (RHHVF)
In a report released today, Keyur Parekh from Goldman Sachs maintained a Buy rating on Roche Holding AG, with a price target of CHF384.00. The company’s shares closed last Tuesday at $349.00.
Parekh has an average return of 14.5% when recommending Roche Holding AG.
According to TipRanks.com, Parekh is ranked #2786 out of 6817 analysts.
Roche Holding AG has an analyst consensus of Strong Buy, with a price target consensus of $416.40, implying a 18.2% upside from current levels. In a report issued on July 16, J.P. Morgan also maintained a Buy rating on the stock with a CHF400.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
